title: The role of imaging techniques in the study of renal osteodystrophy.
abstract: Secondary hyperparathyroidism is the most common form of this condition found in renal osteodystrophy. Enlarged parathyroid glands are the rule in severe secondary hyperparathyroidism because of a marked parathyroid cell hyperplasia. For several years, ultrasonography, computed tomography, and scintigraphy with thallium201-technetium99 have been useful techniques to identify enlarged parathyroid glands. More recently, ultrasonography with color Doppler and parathyroid scintigraphy with 99mTc-sestamibi have proved to be useful as well. Computed tomography and magnetic resonance imaging can be used, but their sensitivity is similar to ultrasonography and they cost more. Ultrasonography with color Doppler signals has made it possible to evaluate tissue blood supply, an aid in differentiating thyroid nodules. The degree of blood supply may be an indirect index of cell proliferation when there is neither necrosis nor calcification, because an enriched blood supply suggests vigorous cell growth and nodule formation. Scintigraphy with 99mTc-sestamibi allows identification of ectopic glands, including those located in the mediastinum, and also provides functional information. Sestamibi uptake is closely related to both parathyroid hormone levels and to the histological type of parathyroid proliferation. In our experience, when hyperparathyroidism is not too severe, 2 weeks after 2 g of calcitriol is administered intravenously, these scintigraphic images can disappear (inhibition test). This suggests a possibility for a medical treatment. By contrast, when parathyroid hormone levels are higher, parathyroid sestamibi uptake remained unchanged. In such patients, parathyroidectomy or ethanol injection should be the best treatment. These glands would correspond to the most actively functioning glands; they would have a lesser expression of vitamin D receptors, rendering them refractory to medical treatment with calcitriol.
authors.affiliation: Nephrology Center, Clinical Hospital, Montevideo, Uruguay.
authors.forename: P
authors.initials: P
authors.lastname: Ambrosoni
authors.forename: I
authors.initials: I
authors.lastname: Olaizola
authors.forename: C
authors.initials: C
authors.lastname: Heuguerot
authors.forename: M N
authors.initials: MN
authors.lastname: Parodi
authors.forename: H
authors.initials: H
authors.lastname: Caorsi
authors.forename: S
authors.initials: S
authors.lastname: Caputti
authors.forename: J
authors.initials: J
authors.lastname: López
authors.forename: N
authors.initials: N
authors.lastname: Di Trápani
authors.forename: A
authors.initials: A
authors.lastname: Petraglia
mesh_terms: D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000150:complications*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D010280:Parathyroid Glands / Q000000981:diagnostic imaging* / Q000473:pathology; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed; D018615:Ultrasonography, Doppler, Color
chemical_list: D017256:Technetium Tc 99m Sestamibi